David R. Lally, MD, discusses promising results from the ARCHER trial on ANX007 for age-related macular degeneration, emphasizing the need for vision-preserving treatments.
David R. Lally, MD
Advertisement
Articles by David R. Lally, MD
Advertisement
Latest Updated Articles
Q&A: The ARCHER trial and the importance of continued GA researchOctober 13th 2025
Advertisement
Advertisement
Trending on Modern Retina
1
Johnson & Johnson’s TECNIS PureSee EDOF IOL cleared for US market
2
Eichenbaum Acorns: Collaborative retina care with Jeffry D. Gerson, OD, FAAO
3
NovaBridge, Visara report positive phase 2a results for dual VEGF-A/ANG-2 inhibitor VIS-101
4
Ocugen completes enrollment in liMeliGhT phase 3 trial of OCU400 for retinitis pigmentosa
5